India’s top agrochemical exporters have launched a forceful push against extending data protection rules, warning that such a move would entrench monopolies, raise costs for farmers, and undermine the country’s global dominance in generic crop solutions.

The Crop Care Federation of India (CCFI), an apex trade body representing companies with extensive manufacturing bases and advanced R&D capabilities, says its members account for nearly 80% of India’s agrochemical exports spanning more than 167 countries.

Over the past five years alone, the sector has generated a trade surplus of $16 billion, cementing India’s position among the world’s top three exporters.

At the heart of the debate is a detailed white paper submitted to Agriculture Minister Shivraj Singh Chouhan, arguing that extending protection beyond the standard 20-year patent period would harm domestic manufacturers and contradict the government’s “Atmanirbhar Bharat” and “Make in India” goals.

The federation dismisses claims that innovation would suffer without added protections. Instead, it calls such concerns misplaced, pointing to data showing strong momentum in new product registrations.

In the past two years, India has approved 36 new pesticide molecules—a record that outpaces countries like Brazil, Malaysia, and Thailand, all of which enforce data exclusivity regimes.

CCFI underscores that nearly 90% of the global agrochemical market is already driven by generics, including the world’s top-selling products. India has emerged as a global leader in this segment, supplying cost-effective solutions worldwide.

According to the group, extending exclusivity to off-patent chemicals would delay generic entry, erode competitiveness, and ultimately damage export performance.

The white paper draws heavily on past government and parliamentary positions. Multiple committee reports—from 2008 through 2021—have consistently opposed additional data protection, with one noting that even the existing 20-year patent window may already be excessive in a fast-evolving technological landscape.

The federation also points to India’s legal framework, including the Patents Act, which discourages the hoarding of patents without commercialization. It alleges that several multinational corporations have secured patents for pesticide molecules in India but failed to introduce them domestically, despite launching them abroad.

Another key concern is historical precedent. During what CCFI describes as a “de facto data exclusivity” period between 2007 and 2017, agrochemical imports surged by 547%.

After the removal of such protections, import growth dropped sharply to 17% between 2017 and 2024, alongside a rise in domestic production.

CCFI Chairman Deepak Shah did not mince words: “Allowing data protection/exclusivity would create a strong monopoly beyond patents, delay introduction of generics, raise prices and hurt the farm economy and agrochemical exports.

"Data protection/exclusivity should not be granted in India, as other countries which rely on India’s supply will also suffer. It will considerably erode our export competitiveness to over 160 countries where our quality is well accepted without any rejections”

The stakes, the federation argues, go beyond trade. With Indian agriculture dominated by smallholder farmers, affordability and access to crop protection products are critical. CCFI warns that extended exclusivity would push prices higher, limit access to generics, and weaken rural livelihoods.

The group concludes that granting data protection would hand undue advantage to multinational firms while undermining India’s export-driven agrochemical industry. It frames the issue as not just economic policy, but a strategic choice about self-reliance and farmer welfare in one of the country’s most vital sectors.